Validation and optimization of a polymer system for potential use as a controlled drug-delivery system
- 1 January 1994
- journal article
- Published by Elsevier BV in Clinical Materials
- Vol. 16 (2), 91-98
- https://doi.org/10.1016/0267-6605(94)90102-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Bone matrix mRNA expression in differentiating fetal bovine osteoblastsJournal of Bone and Mineral Research, 1992
- Human growth hormone in polymethyl methacrylateActa Orthopaedica, 1992
- Heterocyclic methacrylates for clinical applications: III. Water absorption characteristicsBiomaterials, 1991
- Heterocyclic methacrylates for clinical applications: II. Boom temperature polymerizing systems for potential clinical useBiomaterials, 1991
- Heterocyclic methacrylates for clinical applications: I. Mechanical propertiesBiomaterials, 1991
- Growth Hormone in Polymethylmethacrylate CementPublished by Ovid Technologies (Wolters Kluwer Health) ,1990
- ESTA: A BIOASSAY SYSTEM FOR THE DETERMINATION OF THE POTENCIES OF HORMONES AND ANTIBODIES WHICH MIMIC THEIR ACTION.Journal of Molecular Endocrinology, 1988
- The effects of two temporary crown materials on the dental pulp of monkeys (Macaca fascicularis)International Endodontic Journal, 1986
- Drug release from acrylic polymers via channels and cracks: In vitro studies with hydrocortisoneBiomaterials, 1985
- Effect of Growth Factors on Bone Cell Replication and DifferentiationClinical Orthopaedics and Related Research, 1985